Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00005878
First received: June 2, 2000
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)
Publications: